Aclaris Therapeutics, Inc. · NASDAQ:ACRS

The Vanguard Group reported a 6.15% stake in Aclaris Therapeutics, Inc. (Schedule 13G)

Event Jun 30, 2025 · Filed Jul 29, 2025

The Vanguard Group reported a 6.15% stake in Aclaris Therapeutics, Inc., 6,662,063 shares, as a passive investor on Jun 30, 2025. Filed Jul 29, 2025 (Schedule 13G).

Stake
6.15%
Shares
6,662,063
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
The Vanguard Group6.15%6,662,063

Source

View original at SEC

Related